This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2018-02-09 CDAMG Conference Call"
Jump to navigation
Jump to search
Lisa Nelson (talk | contribs) |
Lisa Nelson (talk | contribs) |
||
Line 143: | Line 143: | ||
*Approved the minutes from 1/30/2018 | *Approved the minutes from 1/30/2018 | ||
*Approved the CDA R2.1 Stylesheet Creation PSS | *Approved the CDA R2.1 Stylesheet Creation PSS | ||
− | *Approved the CDA/FHIR HAI PSS with | + | *Approved the CDA/FHIR HAI PSS with caveat to make transforms between FHIR and CDA publically available when they are developed--goal is transparency for cross-standard transformations |
*Approved making a request of SGB to add a member to the CDA Management Group that represents the Quality Use Case for CDA | *Approved making a request of SGB to add a member to the CDA Management Group that represents the Quality Use Case for CDA | ||
Latest revision as of 20:13, 9 February 2018
back to CDA Management Group main page
HL7 CDAMG Minutes Location: Conference Call |
Date: 2018-02-09 Time: 2:00 PM (ET) | ||
Facilitator | Brett | Note taker(s) | Lisa |
Attendee | Name
| ||
X | George Dixon | ||
Jean Duteau | |||
X | Rick Geimer | ||
Kai Heitmann | |||
X | Brett Marquard | ||
X | Linda Michaelsen | ||
Dale Nelson | |||
X | Lisa Nelson | ||
Andrew Statler | |||
Quorum: Chair +3 |
Agenda & Minutes
- Welcome Guest: Austin Kreisler (Note: Call was not listed on the HL7 Conference Call Calendar)
- Agenda review
- Approve Minutes of 2018-01-29_CDAMG_WGM
- No changes requested; Approved by consensus
- Review items
- CDA R2.1 Style Sheet Creation PSS
- Motion to approve (Lisa/Rick) 0-0-4
- CDA FHIR HAI PSS
- Discussed the need to have the Transforms from FHIR to CDA IG will eventually be needed in the FHIR IG
- Before the FHIR IG can be considered complete, the mappings between FHIR and CDA should go through ballot. Mapping spreadsheets need to be included as an informative resource.
- Rick expressed concern about mappings getting "locked down" and not allow for easy modifications
- Austin suggested we consider the production of the transforms as an additional component of the project for future consideration
- Brett wants to add, "When transforms are developed, they will be publically available for review."
- Austin - will take the question back to the CDC to see if they would be open to including this adjustment to the Scope Statement.
- Motion to approve with caveat that Scope will be modified to include making transforms publically available (Rick/Lisa) 0-0-4
- CDA R2.1 Style Sheet Creation PSS
- Discussion Topics
- SWOT
- Reviewed the SWOT
- Any updates as a result of activity at the WGM?
- Did we add: How do we manage quality problems for IG's that have already been published? Add as a Weakness list in SWOT.
- A Project has to be initiated to re-affirm an existing IG to extend it for an additional 5 years. CMG could identify low quality IGs and notify WGs that the quality bar has been raised, so issues would need to be addressed prior to re-affirmation.
- Austin suggested we may want to identify low quality CDA IG's now so that workgroups could be notified of the future need
- Can we add: Threat and Opportunity - Trend toward mapping/developing FHIR and CDA interchange guidance simultaneously. Opportunity is to coordinate these efforts for consistency. Threat is decreased interoperability if not many simultaneous efforts produce divergent in inconsistent solutions - YES. Added
- George asked that we add an Opportunity to create an IG to address the USCDI plans for upcoming data classes - Notes and Data Provenance are up next
- Austin explained that Affiliates do not need to bring PSSs to HL7. CMG is International + US focused.
- Asset List - Status, and ongoing management.
- Linda asked if it was ok to add rows for IG's identified by CQI as missing from the asset list. Answer:Yes!
- Discuss Status/Development toward CDA Template Interchange Format
- Discuss Status of CDA Template Registry
- What actions remain to be completed?
- Review progress on CMG Wiki changes - what's left to be completed?
- Discuss need for & Development of overall CDA Product Roadmap
- Roadmap needs to address questions like:
- Envisioned "superceeding" of CDA R2.0 with CDA R2.1 what it means to ANSI and HL7 Publishing and Implementer Use
- Expectation for CDA R2.0 after CDA R2.1 is released?
- Would we require new IGs to be implemented on CDA R2.1 rather than CDA R2.0?
- Austin suggested the CMG may need to decide this or decide when this would take place.
- Austin - actRelationship codes may need to be reconsidered if C-CDA were revised on the CDA R2.1 standard
- Austin mentioned the modeling of the C-CDA Templates would be needed
- Brett asked: Will CDA R2.1 include a complete "delta" view that could be included in the published CDA R2.0
- What happens to C-CDA if CDA R2.0 is superceeded by R2.1?
- Strategies for aligning C-CDA with FHIR?
- Roadmap needs to address questions like:
- Discuss Actions to be taken to solidify "check list procedure" for CMG members to use when reviewing PSSs, Document CMG PSS Review process to be followed (Jean)
- Review minutes from 2018-01-29.
- Is our plan sufficiently clear and actionable? Do we need to document the procedure(s) we will follow regarding where CMG approval is being injected into the HL7 approval processes?
- Learned from Anne Wizauer that the CMG is only responsible for approving PSSs and Publishing Requests.
- In leiu of having a formal check-list, CMG will simply read and review each PSS and PubReq submitted for review
- Discuss Request to add a new member to CMG representing the Quality perspective (Lisa)
- We would need to have a discussion with SGB to make this request
- Does anyone think adding a representative from QRDA would not be a good idea?
- Austin asked if we have current members who are not participating now?
- Brett noted the Friday late afternoon time makes the meeting hard to attend for EU participants
- Lisa asked - how would we ask SGB for this additional role? Austin said we would need to write up the request and submit it to SGB
- Motion to take this up with SGB (Lisa/George) 0-0-4
- Discuss C-CDA Value Set Maintenance situation - what role needed from CMG? (Lisa)
- SWOT
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items |
© 2017 Health Level Seven® International. All rights reserved